A Win For Cyclerion Therapeutics, Inc.
Fri, Jan 31, 2025 at 07:36 PM
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) rocketted at $3.92, representing a gain of 54.3%. On Fri, Jan 31, 2025, CYCN:NASDAQ touched a New 2-Week High of $3.92. From Fri, Jan 17, 2025, the stock recorded 44.44% Up Days and 30.00% Green Days
The stock spiked on Wed, Dec 04, 2024 at $9.47 with a volume of 141M+.
About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.
Top 10 Gainers:
- Tarena International Inc. (TCTM:NASDAQ), 329.82%
- Reborn Coffee Inc. (REBN:NASDAQ), 62.56%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 54.33%
- Society Pass Incorporated (SOPA:NASDAQ), 50.5%
- Signing Day Sports Inc. (SGN:NYSEMKT), 47.66%
- Dunxin Financial Holdings Limited (DXF:NYSEMKT), 45.01%
- F45 Training Holdings Inc. (FXLV:NYSE), 42.86%
- China Liberal Education Holdings Limited (CLEU:NASDAQ), 34.95%
- MiNK Therapeutics Inc. (INKT:NASDAQ), 32.95%
- Envirotech Vehicles Inc. (EVTV:NASDAQ), 31.02%